Table 4.
Baseline characteristics of the patients among different groups in the GSE132607 dataset.
| Characteristics | CD247 | MYL4 | ||||
|---|---|---|---|---|---|---|
| High expression | Low expression | p value | High expression | Low expression | p value | |
| Age (years) | 66.86 ± 7.32 | 66.40 ± 8.04 | 0.796 | 66.52 ± 7.86 | 66.93 ± 7.20 | 0.839 |
| Gender | ||||||
| Female | 8 (21.6) | 14 (37.8) | 0.127 | 15 (27.8) | 7 (35.0) | 0.546 |
| Male | 29 (78.4) | 23 (62.2) | 39 (72.2) | 13 (65.0) | ||
| Smoking | ||||||
| No | 12 (32.4) | 13 (35.1) | 1.000 | 15 (27.8) | 10 (50.0) | 0.073 |
| Yes | 25 (67.6) | 24 (64.9) | 39 (72.2) | 10 (50.0) | ||
| Baseline | ||||||
| FVC% predicted | 72.14 ± 20.64 | 67.25 ± 15.9 | 0.259 | 67.89 ± 17.8 | 74.69 ± 19.7 | 0.168 |
| Dlco% predicted | 49.78 ± 15.72 | 41.44 ± 14.2 | 0.019 | 42.76 ± 14.6 | 53.28 ± 15.5 | 0.008 |
| 4 months | ||||||
| FVC% predicted | 71.62 ± 20.33 | 65.72 ± 15.9 | 0.171 | 66.04 ± 18.4 | 75.50 ± 16.8 | 0.049 |
| Dlco% predicted | 48.78 ± 15.14 | 39.23 ± 13.1 | 0.006 | 39.97 ± 13.2 | 54.51 ± 14.1 | < 0.001 |
| 8 months | ||||||
| FVC% predicted | 72.31 ± 20.35 | 65.35 ± 15.3 | 0.118 | 65.82 ± 18.2 | 76.07 ± 16.8 | 0.034 |
| Dlco% predicted | 49.51 ± 13.58 | 39.16 ± 15.4 | 0.006 | 40.73 ± 14.6 | 53.21 ± 13.6 | 0.002 |
| 12 months | ||||||
| FVC% predicted | 68.63 ± 21.55 | 64.36 ± 14.5 | 0.375 | 64.94 ± 18.0 | 70.49 ± 18.8 | 0.301 |
| Dlco% predicted | 46.02 ± 15.32 | 37.33 ± 12.5 | 0.019 | 38.65 ± 12.9 | 49.46 ± 16.1 | 0.009 |